Abstract
Effects of aging on hepatic expression and activity of cytochrome P450 (CYP) isoforms were investigated in male mice aged 2, 6, 18, and 30 months. Microsomal protein, total CYP, cytochrome b5 and NADPH-dependent cytochrome P450 reductase contents in liver were fully expressed in young (2-month-old) mice. Neither Cyp1a1 nor Cyp2c was detected in any aged mice. And Cyp1a2 was maximally expressed at 2 months and decreased with age. Hepatic levels of Cyp2b10 and Cyp3a11 were decreased in 30-month-old mice. Hepatic Cyp2e1 levels were constantly maintained from 2-month to 30-month old mice. Hepatic activities of ethoxyresorufin–O-deethylase and methoxyresorufin–O-demethylase were gradually decreased after 6 months. The 30-month-old mice exhibited the lowest activity of midazolam 1′-hydroxylase. Pentoxyresorufin–O-depenthylase activity was decreased in 30-month-old mice, but not statistically significant. There were no significant differences in hepatic activities of chlorzoxazone 6-hydroxylase and midazolam 4-hydroxylase. The present study shows that increasing age, especially 30-month-old mice, leads to decrease in expression and activity of hepatic CYP isoforms, suggesting that aging mice exhibit poor hepatic drug-metabolizing capacity.
Similar content being viewed by others
References
Burke, M.D., S. Thompson, R.J. Weaver, C.R. Wolf, and R.T. Mayer. 1994. Cytochrome P450 specificities of alkoxyresorufin O dealkylation in human and rat liver. Biochemical Pharmacology 48: 923–936.
Chen, J.J., G.S. Chen, and N.J. Bunce. 2003. Inhibition of CYP 1A2-dependent MROD activity in rat liver microsomes: an explanation of the hepatic sequestration of a limited subset of halogenated aromatic hydrocarbons. Environmental Toxicology 18: 115–119.
Chovan, J.P., S.C. Ring, E. Yu, and J.P. Baldino. 2007. Cytochrome P450 probe substrate metabolism kinetics in Sprague-Dawley rats. Xenobiotica 37: 459–473.
Cotreau, M.M., L.L. von Moltke, M.C. Beinfeld, and D.J. Greenblatt. 2000. Methodologies to study the induction of rat hepatic and intestinal cytochrome P450 3A at the mRNA, protein, and catalytic activity level. Journal of Pharmacological and Toxicological Methods 43: 41–54.
Estabrook, R.W., and J. Werringloer. 1978. The measurement of difference spectra: application to the cytochromes of microsomes. Methods in Enzymology 52: 212–220.
Imaoka, S., S. Fujita, and Y. Funae. 1991. Age-dependent expression of cytochrome P-450 s in rat liver. Biochimica et Biophysica Acta 1097: 187–192.
Isabelle, L., I. Leclercq, Y. Horsmans, and J.P. Desager. 1998. Estimation of chlorzoxazone hydroxylase activity in liver microsomes and of the plasma pharmacokinetics of chlorzoxazone by the same high-performance liquid chromatographic method. Journal of Chromatography A 828: 291–296.
Kim, S.K., and R.F. Novak. 2007. The role of intracellular signaling in insulin-mediated regulation of drug metabolizing enzyme gene and protein expression. Pharmacology & Therapeutics 113: 88–120.
Kitada, M., M. Taneda, K. Itahashi, and T. Kamataki. 1991. Four forms of cytochrome P-450 in human fetal liver: Purification and their capacity to activate promutagens. Japanese Journal of Cancer Research 82: 426–432.
Kobayashi, K., K. Urashima, N. Shimada, and K. Chiba. 2002. Substrate specificity for rat cytochrome P450 (CYP) isoforms: Screening with cDNA-expressed systems of the rat. Biochemical Pharmacology 63: 889–896.
Liptrott, N.J., M. Penny, P.G. Bray, J. Sathish, S.H. Khoo, D.J. Back, and A. Owen. 2009. The impact of cytokines on the expression of drug transporters, cytochrome P450 enzymes, and chemokine receptors in human PBMC. British Journal of Pharmacology 156: 497–508.
Lowry, O.H., N.G. Rosebrough, A.L. Farr, and R.J. Randall. 1951. Protein measurement with Folin phenol reagent. Journal of Biological Chemistry 193: 265–275.
Maeda, K., T. Kamataki, T. Nagai, and R. Kato. 1984. Postnatal development of constitutive forms of cytochrome P-450 in liver microsomes of male and female rats. Biochemical Pharmacology 33: 509–512.
Martignoni, M., G.M. Groothuis, and R. de Kanter. 2006. Species differences between mouse, rat, dog, monkey and human CYP-mediated drug metabolism, inhibition and induction. Expert Opinion on Drug Metabolism & Toxicology 6: 875–894.
Minn, A.L., H. Pelczar, C. Denizot, M. Martinet, J.M. Heydel, B. Walther, A. Minn, H. Goudonnet, and Y. Artur. 2006. Characterization of microsomal cytochrome P450-dependent monooxygenases in the rat olfactory mucosa. Drug Metabolism & Toxicology 6: 875–894.
Omiecinski, C.J., C.A. Redlich, and P. Costa. 1990. Induction and developmental expression of cytochrome P450IA1 messenger RNA in rat and human tissues: detection by the polymerase chain reaction. Cancer Research 50: 4315–4321.
Omura, T., and R. Sato. 1964. The carbon monoxide-binding pigment of liver microsomes. I. Evidence for its hemoprotein nature. Journal of Biological Chemistry 239: 2370–2378.
Schenkman, J.B., K.E. Thummel, and L.V. Favreau. 1989. Physiological and pathophysiological alterations in rat hepatic cytochrome P-450. Drug Metabolism Reviews 20: 557–584.
Strobel, H.W., and J.D. Dignam. 1978. Purification and properties of NADPH-cytochrome P-450 reductase. Methods in Enzymology 52: 89–96.
Tani, Y., H. Yamamoto, A. Kawaji, H. Mizuno, J. Fukushige, T. Hosokawa, and K. Doi. 1999. Hepatic cytochrome P450 and flavin-containing monooxygenase in male Nts: Mini rat, a transgenic rat carrying antisense RNA transgene for rat growth hormone. Toxicology Letters 106: 159–169.
Wauthier, V., R.K. Verbeeck, and P.B. Calderon. 2007. The effect of ageing on cytochrome p450 enzymes: Consequences for drug biotransformation in the elderly. Current Medicinal Chemistry 14: 745–757.
Yang, M.J., S. Sim, J.H. Jeon, E. Jeong, H.-C. Kim, Y.-H. Park, and I.-B. Kim. 2013. Mitral and tufted cells are potential cellular targets of nitration in the olfactory bulb of aged mice. PLoS ONE 8: e59673.
Yun, K.U., S.J. Oh, J.M. Oh, K.W. Kang, C.S. Myung, G.Y. Song, B.H. Kim, and S.K. Kim. 2010. Age-related changes in hepatic expression and activity of cytochrome P450 in male rats. Archives of Toxicology 84: 939–946.
Acknowledgments
This study was supported by a Grant from the Korea Healthcare Technology R&D Project, Ministry for Health, Welfare, & Family Affairs, Republic of Korea (A101836) and by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (2013R1A1A2005981).
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
About this article
Cite this article
Kwak, H.C., Kim, H.C., Oh, S.J. et al. Effects of age increase on hepatic expression and activity of cytochrome P450 in male C57BL/6 mice. Arch. Pharm. Res. 38, 857–864 (2015). https://doi.org/10.1007/s12272-014-0452-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12272-014-0452-z